Rare case report of an aggressive follicular lymphoid hyperplasia in maxilla

Springer Science and Business Media LLC - Tập 21 - Trang 475-481 - 2017
João Adolfo Costa Hanemann1, Marina Lara de Carli1, Ernesto Rabello Dendena2, Carlos Eduardo Gomes do Couto Filho1, Suzana Catanhede Orsini Machado de Sousa3, Alessandro Antônio Costa Pereira4, Fernanda Salgueiredo Giudice5, Felipe Fornias Sperandio4
1Department of Clinic and Surgery, School of Dentistry, Federal University of Alfenas, Alfenas, Brazil
2Department of Head and Neck Surgery, Bom Pastor Hospital, Varginha, Brazil
3Department of Oral Pathology, School of Dentistry, University of Sao Paulo, Sao Paulo, Brazil
4Department of Pathology and Parasitology, Institute of Biomedical Sciences, Federal University of Alfenas, Alfenas, Brazil
5International Center for Research at A.C. Camargo Cancer Center, R. Professor Antônio Prudente, São Paulo, Brazil

Tóm tắt

Follicular lymphoid hyperplasia is a very rare though benign reactive process of an unknown pathogenesis that may resemble a follicular lymphoma, clinically and histologically. Oral reactive follicular hyperplasia (RFH) has been described on the hard or soft palate and at the base of the tongue. We describe here the first case of RFH presenting as an aggressive tumor on the right posterior side of the maxilla in a 24-year-old male patient. The lesion had a clinical evolution of 18 months and was noticed after the surgical extraction of the right third molar, although we cannot assume a cause-effect relation with that surgical event whatsoever. His medical history was unremarkable. Following an incisional biopsy, histological examination revealed lymphoid follicles comprised by germinal centers surrounded by well-defined mantle zones. The germinal centers were positive for Bcl-6, CD10, CD20, CD21, CD23, CD79a, and Ki-67, while negative for Bcl-2, CD2, CD3, CD5, and CD138. The mantle and interfollicular zones were positive for Bcl-2, CD2, CD3, CD5, CD20, and CD138. Both areas were diffusively positive for kappa and lambda, showing polyclonality. The patient underwent a vigorous curettage of the lesion with no reoccurrences at 36 months of follow-up. This case report demonstrates that morphologic and immunohistochemical analyses are crucial to differentiate RFH from follicular lymphoma, leading to proper management.

Tài liệu tham khảo

Jham BC, Binmadi NO, Scheper MA, Zhao XF, Koterwas GE, Kashyap A et al (2009) Follicular lymphoid hyperplasia of the palate: case report and literature review. J Craniomaxillofac Surg 37:79–82. https://doi.org/10.1016/j.jcms.2008.11.007 Wright JM, Dunsworth AR (1983) Follicular lymphoid hyperplasia of the hard palate: a benign lymphoproliferative process. Oral Surg Oral Med Oral Pathol 55:162–168 Anjomshoaa I, Bulford LA, Dym H, Woo SB (2013) Florid follicular lymphoid hyperplasia of the hard palatal mucosa managed with intralesional steroids: a case report and review of the literature. J Oral Maxillofac Surg 71:1202–1208. https://doi.org/10.1016/j.joms.2013.01.015 Kolokotronis A, Dimitrakopoulos I, Asimaki A (2003) Follicular lymphoid hyperplasia of the palate: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:172–175. https://doi.org/10.1016/S1079210403000957 Mopsik ER, Adrian JC, Klein LE (1992) Follicular lymphoid hyperplasia of the hard palate: report of a case. J Oral Maxillofac Surg 50:538–540 Menasce LP, Shanks JH, Banerjee SS, Harris M (2001) Follicular lymphoid hyperplasia of the hard palate and oral mucosa: report of three cases and a review of the literature. Histopathology 39:353–358 Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetics head and neck tumours. IARC Press, Lyon Philipone E, Bhagat G, Alobeid B (2015) Oral cavity lymphoid neoplasms. A fifteen-year single institution review. N Y State Dent J 81:44–47 Kato H, Kanematsu M, Watanabe H, Kawaguchi S, Mizuta K, Aoki M (2015) Differentiation of extranodal non-Hodgkins lymphoma from squamous cell carcinoma of the maxillary sinus: a multimodality imaging approach. Spring 4:228. https://doi.org/10.1186/s40064-015-0974-y Good DJ, Gascoyne RD (2009) Atypical lymphoid hyperplasia mimicking lymphoma. Hematol Oncol Clin North Am 23:729–745. https://doi.org/10.1016/j.hoc.2009.04.005 Davila MA, Thompson SH (1988) Reactive lymphoid hyperplasia of the hard palate. J Oral Maxillofac Surg 46:1103–1105 Weiss LM, Loera S, Bacchi CE (2010) Immunoglobulin light chain immunohistochemistry revisited, with emphasis on reactive follicular hyperplasia versus follicular lymphoma. Appl Immunohistochem Mol Morphol 18:199–205. https://doi.org/10.1097/PAI.0b013e3181c59a81 Zheng Y, Zhou X, Xie J, Zhu H, Zhang S, Zhang Y et al (2014) IgM expression in paraffin sections distinguishes follicular lymphoma from reactive follicular hyperplasia. Int J Clin Exp Pathol 7:3264–3271 Nathwani BN, Winberg CD, Diamond LW, Bearman RM, Kim H (1981) Morphologic criteria for the differentiation of follicular lymphoma from florid reactive follicular hyperplasia: a study of 80 cases. Cancer 48:1794–1806 Weiss LM, O’Malley D (2013) Benign lymphadenopathies. Mod Pathol 26(Suppl 1):S88–S96. https://doi.org/10.1038/modpathol.2012.176 qsujimoto Y, Cossman J, Jaffe E, Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440–1443 Zutter M, Hockenbery D, Silverman GA, Korsmeyer SJ (1991) Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. Blood 78:1062–1068 Gelb AB, Rouse RV, Dorfman RF, Warnke RA (1994) Detection of immunophenotypic abnormalities in paraffin-embedded B-lineage non-Hodgkin’s lymphomas. Am J Clin Pathol 102:825–834 Lai R, Arber DA, Chang KL, Wilson CS, Weiss LM (1998) Frequency of bcl-2 expression in non-Hodgkin’s lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol 11:864–869 Utz GL, Swerdlow SH (1993) Distinction of follicular hyperplasia from follicular lymphoma in B5-fixed tissues: comparison of MT2 and bcl-2 antibodies. Hum Pathol 24:1155–1158 Napier SS, Newlands C (1990) Benign lymphoid hyperplasia of the palate: report of two cases and immunohistochemical profile. J Oral Pathol Med 19:221–225 Duarte IX, Domeny-Duarte P, Wludarski SC, Natkunam Y, Bacchi CE (2013) Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients. Mod Pathol 26:1183–1196. https://doi.org/10.1038/modpathol.2013.50 Gradowski JF, Jaffe ES, Warnke RA, Pittaluga S, Surti U, Gole LA et al (2010) Follicular lymphomas with plasmacytic differentiation include two subtypes. Mod Pathol 23:71–79. https://doi.org/10.1038/modpathol.2009.146 Santos MR, Servato JP, Cardoso SV, de Faria PR, Eisenberg AL, Dias FL et al (2014) Squamous cell carcinoma at maxillary sinus: clinicopathologic data in a single Brazilian institution with review of literature. Int J Clin Exp Pathol 7:8823–8832 SY S, Bell D, Hanna EY (2014) Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol 18:S149–S156. https://doi.org/10.1055/s-0034-1390014 Kim BS, Vongtama R, Juillard G (2004) Sinonasal undifferentiated carcinoma: case series and literature review. Am J Otolaryngol 25:162–166 Ejaz A, Wenig BM (2005) Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis. Adv Anat Pathol 12:134–143 Wolfish EB, Nelson BL, Thompson LD (2012) Sinonasal tract mucoepidermoid carcinoma: a clinicopathologic and immunophenotypic study of 19 cases combined with a comprehensive review of the literature. Head Neck Pathol 6:191–207. https://doi.org/10.1007/s12105-011-0320-9 Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L (2010) Major and minor salivary gland tumors. Crit Rev Oncol Hematol 74:134–148. https://doi.org/10.1016/j.critrevonc.2009.10.004 Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR et al (2015) Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the national LymphoCare study. J Clin Oncol 33:2516–2522. https://doi.org/10.1200/JCO.2014.59.7534